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Abstract
Background: No consensus definition of macrosomia currently exists among researchers and obstetricians. We
aimed to identify a definition of macrosomia that is more predictive of maternal and perinatal mortality and
morbidity in low- and middle-income countries.
Methods: We conducted a secondary data analysis using WHO Global Survey on Maternal and Perinatal Health
data on Africa and Latin America from 2004 to 2005 and Asia from 2007 to 2008. We compared adverse outcomes,
which were assessed by the composite maternal mortality and morbidity index (MMMI) and perinatal mortality and
morbidity index (PMMI) in subgroups with birthweight (3000–3499 g [reference group], 3500–3999 g, 4000–4099 g,
4100–4199 g, 4200–4299 g, 4300–4399 g, 4400–4499 g, 4500–4999 g) or country-specific birthweight percentile for
gestational age (50th–74th percentile [reference group], 75th–89th, 90th–94th, 95th–96th, and ≥97th percentile).
Two-level logistic regression models were used to estimate odds ratios of MMMI and PMMI.
Results: A total of 246,659 singleton term births from 363 facilities in 23 low- and middle-income countries were
included. Adjusted odds ratios (aORs) for intrapartum caesarean sections exceeded 2.0 when birthweight was
greater than 4000 g (2 · 00 [95 % CI: 1 · 68, 2 · 39], 2 · 42 [95 % CI: 2 · 02, 2 · 89], 2 · 01 [95 % CI: 1 · 74, 2 · 33] in Africa,
Asia and Latin America, respectively). aORs of MMMI reached 2.0 when birthweight was greater than 4000 g, 4500 g
in Asia and Africa, respectively. aORs of PMMI approached to 2.0 (1 · 78 [95 % CI: 1 · 16, 2 · 74]) when birthweight
was greater than 4500 g in Latin America. When birthweight was at the 90th percentile or higher, aORs of MMMI
and PMMI increased, but none exceeded 2.0.
Conclusions: The population-specific definition of macrosomia using birthweight cut-off points irrespective of
gestational age (4500 g in Africa and Latin America, 4000 g in Asia) is more predictive of maternal and perinatal
adverse outcomes, and simpler to apply compared to the definition based on birthweight percentile for a given
gestational age.
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Background
“Macrosomia” is a term that describes a very large fetus or
neonate. The condition may be caused by constitutional/
genetic factors, maternal obesity and/or excessive gesta-
tional weight gain, or maternal hyperglycemia due to pre-
existing diabetes or gestational diabetes that were not
adequately controlled [1]. In low-and middle- income
countries (LMICs) or settings where antenatal care is
sub–optimal, poorly controlled diabetes or undiagnosed
gestational diabetes may be a more important cause for
macrosomia than in high-income countries, where ante-
natal care is better. In high-income countries, the preva-
lence of macrosomia has been increasing in the last two to
three decades [2, 3]. But in many LMICs, macrosomia is
still not perceived to have the same priority as other pub-
lic health problems (e.g., HIV) [4]. However, with the in-
creasing prevalence of maternal obesity and diabetes [5, 6]
a parallel increase in macrosomic infants might be ex-
pected in LMICs. Complicated deliveries related to
macrosomia could lead to more severe adverse outcomes
in resource-poor settings due to limited availability of ob-
stetric care. Thus, a precise definition of macrosomia that
is more predictive of maternal and perinatal mortality
and morbidity is needed. In this study, we aimed to ex-
plore a definition through an outcome-based approach
and comparing commonly used definitions currently.
Currently, no consensus definition exists among re-
searchers and obstetricians. The most commonly used def-
inition is based on birthweight cut-off points (e.g., 4000 g
or 4500 g) [3, 7–9]. As it is increasingly recognized that ra-
cial variation in birthweight is substantial, more and more
studies are using specific birthweight percentiles as cut-off
points at a given gestational week (e.g., P90 or P97) based
on the concept of large-for-gestational-age (LGA) [2, 10].
Furthermore, most studies on macrosomia have focused
on Caucasian populations in high-income countries, and
very few studies on the topic focus on LMICs [2].
In this study we analyzed data from 23 LMICs in Africa,
Asia, and Latin America that participated in the World
Health Organization (WHO) Global Survey on Maternal
and Perinatal Health (2004–2008). We assessed com-
monly used definitions of the term ‘macrosomia’ through
an outcome-based approach. Two types of definitions
were compared: one based on empirical absolute birth-
weight and the other on the country-specific birthweight
percentile at each gestational week. We aimed to identify
a definition that was more predictive of maternal and peri-
natal mortality and morbidity in term pregnancies in
LMICs, which also takes into account regional variation.
Methods
Study design and data extraction
The general objective of the WHO Global Survey on
Maternal and Perinatal Health was to create a global
database on health services and outcomes for maternal
and perinatal health, which concentrated on the relation-
ship between mode of delivery and perinatal outcomes
[2, 11]. This survey has previously been described in
detail elsewhere [2, 11, 12]. A total of 373 facilities in
24 countries in Africa, Asia and Latin America partic-
ipated in this survey. Data collection was carried out
in 2004–05 in Africa and Latin America, and in
2007–08 in Asia. Trained data collectors extracted
data from medical records and completed standard-
ized forms. Gestational age was calculated based on
the difference between the estimated and actual deliv-
ery date in the medical records. Data related to out-
comes were obtained until discharge from the
hospital. Maternal weight was defined differently as
described previously: in Africa and Latin America,
maternal weight was the weight recorded at the first
antenatal care visit, while in Asia it was the weight at
the last visit before delivery [2, 11].
This is a secondary data analysis using data from the
WHO Global Survey on Maternal and Perinatal Health.
The protocol of this survey was approved by the ethics
committees at the WHO and in all participating centres
[11]. We obtained permission to use this data from
Department of Reproductive Health and Research, WHO.
An individual informed consent was not obtained because
in this survey data were extracted from medical records
without individual identification [11].
For the purpose of this analysis, the study sample was
restricted to: 1) LMICs; 2) singleton pregnancies; 3) live
births or fresh stillbirth; 4) birthweight ≥ 1000 g; and 5)
term births (gestational age 37–42 weeks). As the ana-
lysis focused on LMICs, Japan was excluded. Macerated
stillbirths were also excluded, as we were interested in
mortality associated with delivery, but not pre-delivery
mortality. Infants who had missing information on birth-
weight or gestational age were also excluded. The sam-
ple selection process is shown in Fig. 1.
Fig. 1 Flow chart of inclusion and exclusion of study subjects
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Statistical analysis
Previous studies have shown that the perinatal mortality
rate decreases with increasing birthweight or birthweight
percentile until it reaches an inflection point, after which
a further rise in birthweight increases the mortality, i.e.,
a reversed J-shaped mortality curve [13–17]. We applied
this principle to our analysis: macrosomia was defined as
a birthweight or birthweight percentile that exceeds the
nadir of the mortality curve, and at which point the rela-
tive risk of perinatal mortality is twice or greater than
that of the nadir. We used a priori odds ratio of 2 · 0 as
a criterion for clinical significance, as per previous
studies [18, 19].
We used the birthweight range of 3000–3499 g or at
50th–74th percentiles as the reference groups because
our exploratory analyses showed that the nadir of the
birthweight-specific mortality rate fell into these ranges.
According to the exploratory analyses, there was no sig-
nificant difference of risks of neonatal mortality and
morbidity among subgroups of every 100 g between
3500 and 4000 g. Thus, infants with birthweights in the
range of 3500–3999 g were combined as one subgroup.
Birthweights between 4000 and 4500 g were categorized
into subgroups of every 100 g in order to explore the
cut-off point for the definition of macrosomia.
To calculate weight percentiles, we adopted the global
reference for fetal and birth weight percentile [20].
Briefly, based on the mean birthweight and variation at
40 weeks of gestation at each country, country-specific,
equation-derived (i.e., not empirical) birthweight refer-
ence percentiles at 75th, 90th, 95th and 97th for each ges-
tational week were generated. Infant birthweight was
categorized according to these references.
The adverse maternal outcomes included maternal
mortality and severe morbidity defined as any of the
following: admission to an intensive-care unit (ICU), re-
ferral to a higher level or special care unit, blood trans-
fusion, hysterectomy, vesico-vaginal/recto-vaginal fistula
and third or fourth degree perineal laceration. The ad-
verse perinatal outcomes were still-birth, early neonatal
death (neonatal death within 7 days of birth) and severe
neonatal morbidity defined as any of the following: ad-
mission to an Neonatal ICU for 7 days or more, referral
to a higher level or special care unit and 5-min Apgar
score less than four. As maternal and perinatal mortality
and severe morbidity are rare outcomes, the composite
maternal mortality and morbidity index (MMMI) and
perinatal mortality and morbidity index (PMMI) were
computed [2]. The MMMI and PMMI were coded as an
event if mortality or any of the corresponding severe
morbidity occurred. We also compared the risks of
caesarean section and assisted vaginal delivery (for-
ceps/vacuum extraction) for subgroups of infants by
birthweight and birthweight percentile.
Two-level logistic regression models were used to
estimate odds ratios (ORs) of maternal and perinatal
mortality and morbidity by absolute birthweight and
birthweight percentile for gestational age. Facilities rep-
resented units at level two and individuals within facil-
ities were observations at level one. To take into account
the large variations of anthropometry among regions, we
stratified the analysis by region (Africa, Asia and Latin
America). We adjusted for country, maternal age, mari-
tal status, education (total years of school attendance),
obesity (maternal body mass index, BMI ≥30 kg/m2),
pre-existing diabetes, parity, infant sex, and gestational
age as potential confounders according to previous lit-
erature [7, 10]. All analyses were conducted with SAS
version 9 · 2 (SAS Institute Inc, Cary, NC).
Maternal weight and/or height, and consequently ma-
ternal BMI, were missing in more than 10 % of the study
population in Kenya (85 %), Brazil (67 %), Angola
(43 %), Argentina (33 %), Uganda (21 %) and Peru
(13 %). A missing category within “maternal obesity”
(BMI ≥ 30 kg/m2) was therefore created and included in
all regression models. In our sensitivity analysis, we re-
stricted our calculations to countries with less than 10 %
of the missing value for BMI. The “(pre-existing) dia-
betes mellitus” variable was missing in less than 1 % of
the study population of each region. For the estimation
of risks of MMMI and PMMI by birthweight or birth-
weight percentile, we performed a sensitivity analysis by
excluding the variables “maternal obesity” and “diabetes”
from the regression models. In another sensitivity ana-
lysis, we compared the adjusted odds ratios (aORs) of
MMMI and PMMI in subgroups using birthweight per-
centile of the study population as cut-off points, the re-
sults were essentially unchanged (data not shown). In
another sensitivity analysis, we compared the aORs of
MMMI and PMMI in subgroups using the empirical
country- and gestational-age-specific birthweight percent-
ile of the study population as cut-off points, the results
were essentially unchanged (not shown).
Results
A total of 246,659 deliveries at 363 facilities in 23 LMICs
were included in this analysis (Fig. 1). Large variations in
birthweight distribution were observed among infants in
the three regions. Mean birthweight was 3037 g, 3225 g
and 3253 g in Asia, Africa and Latin America, respect-
ively, and the proportion of infants with a birthweight
greater than 4500 g was 0 · 3 %, 1 · 2 %, and 0 · 7 % across
these three regions. The prevalence of birthweight greater
than the 97th percentile was 7.2 % (Latin America), 10.1 %
(Africa) and 10 · 5 % (Asia) in the three regions (Table 1).
In all three regions, the proportion of maternal age older
than 35 years, maternal obesity (BMI ≥30 kg/m2), mater-
nal preexisting gestational diabetes, multiparas and infant
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male sex was positively associated with higher birthweight
(all p values <0 · 0001, Additional file 1: Table S1).
The overall rates of caesarean deliveries (and intra-
partum rate) in Africa, Asia and Latin America were
12 · 0 % (6 · 2 %), 28 · 0 % (12 · 5 %) and 34 · 1 % (12 · 0 %)
(p < 0 · 0001), respectively. Table 2 shows that compared
with the reference group (3000–3499 g), aORs of elective
and intrapartum caesarean section exceeded 2 · 0 when
birthweight was greater than 4000 g in all three regions,
while the risks of forceps or vacuum extraction did not
rise significantly in most subgroups of infants in Asia and
Latin America. In Africa, the aORs of forceps or vacuum
extraction reached 2.0 when birthweight exceeded 4500 g.
There was a large variation of elective caesarean section
rate among populations. In Africa, only around 5 % sus-
pected macrosomic babies were born through elective
caesarean section while in Asia and Latin America, the
responding rate was as high as around 40 and 20 %, re-
spectively. The association between caesarean section and
birthweight seemed less pronounced when infants were
categorized by birthweight percentile and aORs hardly
reached 2.0 (Table 3). The most important indication
for CS for suspected macrosomic cases in all populations
were cephalopelvic disproportion, followed by previous
caesarean and fetal distress. Around 40 % of suspected
macrosomic cases born through caesarean had an indica-
tion of previous caesarean section. The other two indica-
tions accounted for around 30 and 20 % caesarean
deliveries, respectively (Additional file 2: Table S2).
The birthweight-specific risks of MMMI and PMMI
are presented in Fig. 2. The association is expressed in a
reverse “J”- or “U”-shaped curves. In all three regions,
the lowest risk of MMMI corresponded to the birth-
weight range of 3000–3500 g, which was used as the ref-
erence group. When the birthweight exceeded 3500 g,
aORs of MMMI increased gradually. The aORs of
MMMI reached 2 · 0 when birthweight was greater than
4000 g, 4500 g and 5000 g in Asia, Africa and Latin
Table 1 Country-specific birthweight distribution of singleton term births
N Birthweight (g) Birthweight percentile
Mean (SD) ≥4000 (%) ≥4500 (%) ≥P90 (%) ≥P95 (%) ≥P97 (%)
Africa 67546 3225 (489) 7 · 3 1 · 2 20 · 6 12 · 8 10 · 1
Angola 3304 3125 (473) 3 · 1 0 · 7 20 · 8 12 · 8 10 · 4
Algeria 14361 3469 (501) 15 · 2 3 · 2 15 · 4 9 · 1 6 · 9
Democratic Republic of Congo 6989 3077 (452) 2 · 7 0 · 3 22 · 6 15 · 4 11 · 6
Kenya 16091 3158 (448) 3 · 9 0 · 5 23 · 6 15 · 8 12 · 6
Nigeria 7721 3059 (442) 2 · 0 0 · 1 16 · 4 10 · 7 8 · 1
Niger 7296 3215 (494) 8 · 0 1 · 5 19 · 2 10 · 5 8 · 4
Uganda 11784 3252 (464) 9 · 1 0 · 8 25 · 2 14 · 6 12 · 2
Asia 91595 3037 (464) 2 · 5 0 · 3 20 · 3 13 · 8 10 · 5
Cambodia 5052 3090 (419) 2 · 5 0 · 5 16 · 6 11 · 2 9 · 1
China 13595 3333 (419) 7 · 2 0 · 7 17 · 6 10 · 0 7 · 2
India 18828 2772 (424) 0 · 6 0 · 0 28 · 2 22 · 2 16 · 6
Nepal 7316 2958 (469) 1 · 7 0 · 2 18 · 0 12 · 2 8 · 4
Philippines 11946 2961 (425) 1 · 1 0 · 2 19 · 0 12 · 2 9 · 1
Sri Lanka 13787 2980 (424) 1 · 3 0 · 1 20 · 3 13 · 9 10 · 5
Thailand 8621 3137 (437) 2 · 5 0 · 3 20 · 9 13 · 5 10 · 1
Vietnam 12450 3209 (404) 3 · 5 0 · 3 14 · 8 8 · 7 8 · 0
Latin America 87518 3253 (455) 5 · 5 0 · 7 15 · 7 9 · 7 7 · 2
Argentina 9592 3345 (453) 7 · 5 1 · 1 12 · 8 7 · 4 5 · 0
Brazil 13373 3223 (446) 4 · 4 0 · 5 14 · 8 9 · 2 6 · 7
Cuba 11817 3316 (459) 7 · 6 1 · 0 15 · 6 9 · 7 7 · 1
Ecuador 11359 3117 (440) 2 · 9 0 · 3 14 · 7 9 · 8 6 · 7
Mexico 18653 3199 (444) 4 · 1 0 · 5 17 · 5 10 · 5 8 · 2
Nicaragua 5188 3157 (435) 3 · 0 0 · 3 21 · 6 14 · 9 11 · 7
Paraguay 3051 3389 (472) 10 · 2 1 · 8 16 · 3 10 · 1 7 · 4
Peru 14485 3348 (442) 7 · 4 0 · 9 14 · 8 9 · 0 6 · 6
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Table 2 Prevalence and odds ratios of elective caesarean, intrapartum caesarean section and forceps or vacuum extraction by birthweight
Birthweight
(g)
Elective caesarean section Intrapartum caesarean section Forceps extraction or vacuum extraction
N Prevalence (%) Adjusted OR (95 % CI)a p value Prevalence (%) Adjusted OR (95 % CI)a p value Prevalence (%) Adjusted OR (95 % CI)a p value
Africa 67546
3000–3499 28788 1.9 1 · 00 – 5 · 8 1 · 00 – 1 · 8 1 · 00 –
3500–3999 15824 2.3 1.19 (1.03, 1.39) 0.0196 6 · 4 1 · 27 (1 · 16, 1 · 38) <0 · 0001 2 · 4 1 · 22 (1 · 05, 1 · 41) 0 · 0094
4000–4099 2154 2.1 1.14 (0.79, 1.63) 0.4824 9 · 0 2 · 00 (1 · 68, 2 · 39) <0 · 0001 2 · 9 1 · 81 (1 · 35, 2 · 44) 0 · 0001
4100–4199 670 4.2 1.96 (1.25, 3.07) 0.0032 8 · 1 1 · 87 (1 · 38, 2 · 53) 0 · 0001 3 · 4 1 · 64 (1 · 03, 2 · 6) 0 · 0358
4200–4299 686 5.0 2.61 (1.72, 3.96) <0 · 0001 9 · 6 2 · 36 (1 · 78, 3 · 12) <0 · 0001 2 · 2 1 · 09 (0 · 63, 1 · 88) 0 · 7618
4300–4399 377 2.0 0.83 (0.36, 1.93) 0.6687 10 · 6 2 · 39 (1 · 67, 3 · 42) <0 · 0001 2 · 7 0 · 98 (0 · 50, 1 · 92) 0 · 9555
4400–4499 239 5.7 3.26 (1.67, 6.34) 0.0005 8 · 8 2 · 48 (1 · 52, 4 · 04) 0 · 0003 3 · 3 1 · 84 (0 · 86, 3 · 93) 0 · 1131
4500–4999 648 6.3 3.62 (2.40, 5.46) <0 · 0001 13 · 0 3 · 78 (2 · 90, 4 · 92) <0 · 0001 3 · 7 2 · 17 (1 · 37, 3 · 42) 0 · 0009
≥ 5000 146 5.0 2.99 (1.12, 7.95) 0.0287 14 · 4 5 · 11 (3 · 00, 8 · 72) <0 · 0001 8 · 9 8 · 34 (4 · 22, 16 · 5) <0 · 0001
Asia 91595
3000–3499 36479 11.8 1 · 00 – 13 · 2 1 · 00 – 2 · 7 1 · 00 –
3500–3999 13539 18.3 1.36 (1.27, 1.47) <0 · 0001 18 · 6 1 · 44 (1 · 36, 1 · 53) <0 · 0001 2 · 6 1 · 27 (1 · 12, 1 · 45) 0 · 0003
4000–4099 945 31.6 2.33 (1.90, 2.86) <0 · 0001 24 · 1 2 · 42 (2 · 02, 2 · 89) <0 · 0001 2 · 1 1 · 64 (1 · 02, 2 · 64) 0 · 0413
4100–4199 492 34.8 2.32 (1.76, 3.07) <0 · 0001 26 · 6 2 · 61 (2 · 05, 3 · 33) <0 · 0001 2 · 2 1 · 69 (0 · 87, 3 · 29) 0 · 1195
4200–4299 320 40.3 3.19 (2.28, 4.47) <0 · 0001 28 · 1 3 · 79 (2 · 77, 5 · 18) <0 · 0001 3 · 1 2 · 73 (1 · 37, 5 · 46) 0 · 0045
4300–4399 183 40.5 2.63 (1.70, 4.07) <0 · 0001 30 · 1 3 · 29 (2 · 22, 4 · 88) <0 · 0001 2 · 2 2 · 56 (0 · 87, 7 · 55) 0 · 0884
4400–4499 101 47.6 3.45 (1.90, 6.25) <0 · 0001 29 · 7 4 · 13 (2 · 38, 7 · 15) <0 · 0001 2 · 0 1 · 92 (0 · 42, 8 · 67) 0 · 3969
4500–4999 200 50.0 5.48 (3.45, 8.70) <0 · 0001 30 · 0 5 · 20 (3 · 45, 7 · 83) <0 · 0001 2 · 0 2 · 47 (0 · 81, 7 · 57) 0 · 1124
≥ 5000 52 40.0 4.20 (1.71, 10.34) 0.0018 32 · 7 9 · 44 (3 · 99, 22 · 35) <0 · 0001 1 · 9 2 · 38 (0 · 3, 18 · 81) 0 · 4113
Latin America 87518
3000–3499 38930 15.3 1 · 00 – 11 · 2 1 · 00 – 1 · 2 1 · 00 –
3500–3999 20875 16.9 1.19 (1.13, 1.26) <0 · 0001 14 · 0 1 · 28 (1 · 21, 1 · 35) <0 · 0001 1 · 5 1 · 51 (1 · 30, 1 · 77) <0 · 0001
4000–4099 1675 21.7 1.64 (1.40, 1.91) <0 · 0001 18 · 1 2 · 01 (1 · 74, 2 · 33) <0 · 0001 0 · 7 0 · 80 (0 · 43, 1 · 48) 0 · 4699
4100–4199 1020 23.0 1.92 (1.58, 2.34) <0 · 0001 19 · 1 2 · 19 (1 · 83, 2 · 62) <0 · 0001 1 · 3 1 · 45 (0 · 79, 2 · 65) 0 · 2318
4200–4299 757 25.1 2.01 (1.60, 2.51) <0 · 0001 21 · 7 2 · 48 (2 · 03, 3 · 03) <0 · 0001 1 · 5 1 · 88 (0 · 99, 3 · 58) 0 · 0551
4300–4399 466 22.6 1.95 (1.45, 2.61) <0 · 0001 24 · 4 3 · 00 (2 · 35, 3 · 84) <0 · 0001 0 · 9 0 · 90 (0 · 32, 2 · 50) 0 · 8354
4400–4499 281 28.7 2.59 (1.83, 3.66) <0 · 0001 19 · 6 2 · 66 (1 · 89, 3 · 73) <0 · 0001 1 · 1 1 · 81 (0 · 55, 5 · 94) 0 · 3257
4500–4999 569 38.1 3.66 (2.87, 4.68) <0 · 0001 23 · 8 4 · 17 (3 · 29, 5 · 3) <0 · 0001 1 · 1 1 · 98 (0 · 84, 4 · 63) 0 · 1163
≥ 5000 55 35.3 3.54 (1.67, 7.53) 0.0010 20 · 0 3 · 13 (1 · 43, 6 · 85) 0 · 0045 3 · 6 4 · 64 (0 · 95, 22 · 64) 0 · 0579
aAll estimates were based on two-level logistic regression models. Facilities represent units at level two and individuals within facilities are observations at level one. We adjusted for country, maternal age, marital sta-













America, respectively. The rise in PMMI risks lagged
behind that of MMMI in all three regions (Fig. 2).
The aORs of PMMI reached 2 · 0 when birthweight
was greater than 4200 g in Asia and 5000 g in Africa.
In Latin America, birthweight of 4500–4999 g corresponded
to the aOR of PMMI 1 · 78 (95 % CI: 1 · 16, 2 · 74).
When birthweight was greater than 5000 g, aOR rose
dramatically to 7 · 40 (95 % CI: 3 · 5, 15 · 66) (Table 4).
When we excluded prelabor caesarean deliveries or re-
stricted the analyses to vaginal deliveries, the results
remained essentially unchanged (Additional file 3: Tables
S3 and S4).



















P50−P74 15747 1.8 1 · 00 – 5 · 5 1 · 00 – 1 · 9 1 · 00 –
P75–P89 10150 2.3 1.31 (1.08, 1.59) 0.0067 6 · 5 1 · 23 (1 · 10, 1 · 38) 0 · 0002 1 · 8 1 · 18 (0 · 97, 1 · 44) 0 · 1032
P90–P94 5247 2.5 1.36 (1.08, 1.72) 0.0093 6 · 0 1 · 25 (1 · 09, 1 · 44) 0 · 0019 1 · 8 1 · 39 (1 · 08, 1 · 78) 0 · 0106
P95–P96 1820 3.6 1.91 (1.40, 2.60) <0 · 0001 6 · 8 1 · 46 (1 · 18, 1 · 79) 0 · 0004 1 · 2 1 · 02 (0 · 64, 1 · 62) 0 · 9335
≥ P97 6851 3.8 2.00 (1.64, 2.44) <0 · 0001 9 · 0 2 · 17 (1 · 92, 2 · 44) <0 · 0001 1 · 7 1 · 86 (1 · 46, 2 · 37) <0 · 0001
Asia 91595
P50–P74 18066 12.3 1 · 00 – 12 · 5 1 · 00 – 2 · 6 1 · 00 –
P75–P89 14694 12.1 1.08 (1.00, 1.18) 0.0611 12 · 8 1 · 11 (1 · 03, 1 · 19) 0 · 0056 2 · 5 1 · 08 (0 · 93, 1 · 25) 0 · 3198
P90–P94 5955 16.1 1.22 (1.10, 1.36) 0.0002 14 · 9 1 · 37 (1 · 25, 1 · 51) <0 · 0001 2 · 2 1 · 05 (0 · 86, 1 · 29) 0 · 6286
P95–P96 3030 14.5 1.31 (1.14, 1.51) 0.0002 13 · 4 1 · 60 (1 · 41, 1 · 82) <0 · 0001 3 · 2 1 · 67 (1 · 32, 2 · 11) <0 · 0001
≥ P97 9574 18.1 1.65 (1.50, 1.81) <0 · 0001 17 · 2 1 · 90 (1 · 75, 2 · 06) <0 · 0001 3 · 0 1 · 55 (1 · 31, 1 · 83) <0 · 0001
Latin America 87518
P50–P74 20003 15.8 1 · 00 – 12 · 3 1 · 00 – 1 · 3 1 · 00 –
P75–P89 12912 17.7 1.11 (1.03, 1.19) 0.0062 12 · 7 1 · 08 (1 · 01, 1 · 17) 0 · 0291 1 · 3 1 · 13 (0 · 91, 1 · 39) 0 · 2628
P90–P94 5227 19.9 1.27 (1.16, 1.40) <0 · 0001 13 · 8 1 · 33 (1 · 21, 1 · 47) <0 · 0001 1 · 7 1 · 55 (1 · 20, 2 · 02) 0 · 0010
P95–P96 2242 21.7 1.42 (1.24, 1.63) <0 · 0001 15 · 0 1 · 45 (1 · 26, 1 · 66) <0 · 0001 1 · 2 1 · 34 (0 · 88, 2 · 06) 0 · 1770
≥ P97 6284 25.2 1.65 (1.51, 1.80) <0 · 0001 15 · 5 1 · 84 (1 · 68, 2 · 02) <0 · 0001 1 · 2 1 · 34 (1 · 01, 1 · 78) 0 · 0402
aAll estimates were based on two-level logistic regression models. Facilities represent units at level two and individuals within facilities are observations at level





























































Maternal mortality and morbidity index Perinatal mortality and morbidity index
Fig. 2 Adjusted odds ratios of maternal and perinatal mortality and morbidity by birthweight in singleton term births. a: Africa b: Asia c: Latin
America reference category: 3000 –3499 g
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Table 5 shows that the risks of MMMI and PMMI in
infants with a birthweight greater than the 95th percent-
ile increased slightly compared with that of birthweight
at the 50th–75th percentiles in all three regions. When
birthweight was at the 97th percentile or higher, the
aORs of MMMI and PMMI increased significantly, but
none exceeded 2 · 0 in any region. In addition to the
equation-derived global reference birthweight percen-
tiles, we also used the empirical country- and gestational-
age-specific birthweight percentile of the study population
as cut-off points. The results were essentially unchanged
(not shown).
We conducted sensitivity analyses using mortality and
morbidity as two separate outcomes. The mortality in-
cluded maternal and perinatal deaths. For morbidity, the
occurrence of any components of MMMI and PMMI
(excluding maternal or perinatal death) was considered
as a positive event. As maternal and perinatal mortality
were rare, no significant differences in mortality were
found in the subgroups of infants with a birthweight
greater than 4500 g, or the 97th birthweight percentile
compared with the reference groups. However, results
were similar for maternal and perinatal morbidity after
excluding maternal or perinatal death (data no shown).
Table 4 Prevalence and odds ratios of maternal and perinatal mortality and morbidity by birthweight
Birthweight
(g)
N Maternal mortality and morbidity Perinatal mortality and morbidity
Prevalence (%) Adjusted OR (95 % CI)a p value Prevalence (%) Adjusted OR (95 % CI)a p value
Africa 67546 N = 67546
3000–3499 28788 6 · 0 1 · 00 – 4 · 6 1 · 00 –
3500–3999 15824 7 · 2 1 · 10 (1 · 01, 1 · 20) 0 · 0289 4 · 2 0 · 94 (0 · 85, 1 · 05) 0 · 2718
4000–4099 2154 9 · 1 1 · 43 1 · 20, 1 · 70) 0 · 0001 4 · 0 0 · 97 (0 · 76, 1 · 23) 0 · 7780
4100–4199 670 10 · 6 1 · 48 (1 · 12, 1 · 96) 0 · 0061 3 · 4 0 · 93 (0 · 60, 1 · 44) 0 · 7424
4200–4299 686 11 · 7 1 · 59 (1 · 22, 2 · 07) 0 · 0006 3 · 4 0 · 84 (0 · 55, 1 · 31) 0 · 4473
4300–4399 377 14 · 3 1 · 68 (1 · 21, 2 · 34) 0 · 0021 5 · 0 1 · 29 (0 · 79, 2 · 09) 0 · 3122
4400–4499 239 15 · 5 2 · 26 (1 · 51, 3 · 39) 0 · 0001 3 · 8 1 · 26 (0 · 63, 2 · 49) 0 · 5147
4500–4999 648 15 · 0 1 · 84 (1 · 44, 2 · 36) <0 · 0001 5 · 4 1 · 34 (0 · 93, 1 · 93) 0 · 1216
≥ 5000 146 21 · 2 3 · 01 (1 · 91, 4 · 74) <0 · 0001 14 · 4 3 · 79 (2 · 28, 6 · 30) <0 · 0001
Asia 91595 N = 91595
3000–3499 36479 4 · 7 1 · 00 – 1 · 7 1 · 00 –
3500–3999 13539 5 · 4 1 · 38 (1 · 24, 1 · 52) <0 · 0001 1 · 6 1 · 05 (0 · 90, 1 · 24) 0 · 5196
4000–4099 945 5 · 4 1 · 86 (1 · 35, 2 · 56) 0 · 0002 2 · 1 1 · 49 (0 · 94, 2 · 35) 0 · 0891
4100–4199 492 6 · 7 2 · 25 (1 · 50, 3 · 38) 0 · 0001 1 · 2 1 · 01 (0 · 45, 2 · 29) 0 · 9812
4200–4299 320 5 · 0 2 · 03 (1 · 17, 3 · 52) 0 · 0122 4 · 1 2 · 80 (1 · 58, 4 · 99) 0 · 0005
4300–4399 183 11 · 5 4 · 42 (2 · 60, 7 · 50) <0 · 0001 3 · 3 2 · 44 (1 · 06, 5 · 64) 0 · 0366
4400–4499 101 7 · 9 3 · 81 (1 · 68, 8 · 60) 0 · 0013 4 · 0 2 · 99 (1 · 07, 8 · 34) 0 · 0367
4500–4999 200 10 · 0 3 · 38 (1 · 99, 5 · 74) <0 · 0001 6 · 0 4 · 12 (2 · 24, 7 · 56) <0 · 0001
≥ 5000 52 17 · 3 7 · 51 (3 · 25, 17 · 33) <0 · 0001 26 · 9 28 · 44 (14 · 81, 54 · 61) <0 · 0001
Latin America 87518 N = 87518
3000–3499 38930 2 · 4 1 · 00 – 2 · 1 1 · 00 –
3500–3999 20875 2 · 6 1 · 15 (1 · 03, 1 · 28) 0 · 0157 2 · 0 0 · 94 (0 · 83, 1 · 06) 0 · 3390
4000–4099 1675 3 · 0 1 · 44 (1 · 08, 1 · 94) 0 · 0145 2 · 3 1 · 07 (0 · 77, 1 · 49) 0 · 6852
4100–4199 1020 2 · 6 1 · 28 (0 · 86, 1 · 90) 0 · 2229 2 · 2 0 · 98 (0 · 64, 1 · 52) 0 · 9422
4200–4299 757 2 · 5 1 · 05 (0 · 65, 1 · 70) 0 · 8450 2 · 8 1 · 22 (0 · 78, 1 · 91) 0 · 3719
4300–4399 466 3 · 0 1 · 34 (0 · 77, 2 · 31) 0 · 3014 2 · 1 0 · 94 (0 · 5, 1 · 77) 0 · 8429
4400–4499 281 2 · 8 1 · 19 (0 · 58, 2 · 46) 0 · 6381 2 · 8 1 · 25 (0 · 61,2 · 56) 0 · 5378
4500–4999 569 3 · 5 1 · 54 (0 · 96, 2 · 45) 0 · 0708 4 · 0 1 · 78 (1 · 16, 2 · 74) 0 · 0089
≥ 5000 55 5 · 5 2 · 36 (0 · 70, 8 · 00) 0 · 1671 16 · 4 7 · 40 (3 · 50, 15 · 66) <0 · 0001
aAll estimates were based on two-level logistic regression models. Facilities represent units at level two and individuals within facilities are observations at level
one. We adjusted for country, maternal age, marital status, education (total years of school attendance), obesity, diabetes, parity, infant sex, and gestational age
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Similar trends for the risks of MMMI and PMMI by
birthweight and birthweight percentile were found when
we restricted the analyses to countries with less than
10 % of missing value for BMI (Additional file 3: Tables
S5 and S6). When maternal obesity and diabetes were
excluded from the regression models, aORs became
larger for most of the subgroups, but the patterns
remained the same in the three regions (Additional
file 3: Tables S7 and S8).
Discussion
Our results indicate that there is a significant increase in
adverse maternal and perinatal outcomes when the
birthweight of term infants (37–42 weeks) reaches 4500 g
in African and Latin America, and 4000 g in Asia. These
cut-offs could, therefore, be used to define ‘macrosomia’
in these settings. Our findings do not support using LGA
as a new definition for macrosomia because LGA was less
predictive of adverse outcomes.
The use of the cut-off point of 4500 g to define macro-
somia is consistent with results of previous studies of
Caucasians populations [1, 9], and supports the defin-
ition of the American Congress of Obstetricians and Gy-
necologists [1]. Based on analyses of national datasets of
the United States, Zhang et al. [7], found that infants
with birthweight of 4500–4999 g were at significantly in-
creased risks of stillbirth, neonatal mortality (especially
because of birth asphyxia), morbidity, and caesarean de-
livery as a consequence of either slow labor progress or
non-reassuring cardiotocography. Ye et al. [9] used the
same database also found that risks of MMMI or PMMI
did not increased significantly until birthweight was at the
97th percentile or higher. A birthweight cut-off points irre-
spective of gestational age (4500 g in Whites, 4300 g in
Blacks and Hispanics) is more predictive of mortality and
morbidity outcomes than the 97th percentile for a given
gestational age.
We used an OR of 2 · 0 for either MMMI or PMMI as
a priori criterion to identify clinically important macro-
somia. Though arbitrary, this cut-off point was also used
in a study by Boulet et al. [18] in defining clinically im-
portant fetal growth restriction. In the randomized trial
of the Twin Birth Study Collaborative Group, a relative
risk of 0 · 5 was also used to justify the smallest clinically
important difference between the planned caesarean
delivery group and control group [19], equivalent to
two-fold increase (or decrease) of risks.
Using the concept of birthweight percentile at a given
gestational age (i.e., LGA) as the definition of macroso-
mia has been proposed in recent years [2, 10, 21]. How-
ever, our study shows that it has a poor prediction of
adverse maternal and perinatal outcomes. This may be
partially attributable to the imprecise estimation of ges-
tational age, which has resulted in misclassifications of
Table 5 Prevalence and odds ratios of maternal and perinatal mortality and morbidity by birthweight percentile
Birthweight
percentile
N Maternal mortality and morbidity Perinatal mortality and morbidity
Prevalence (%) Adjusted OR (95 % CI)a p value Prevalence (%) Adjusted OR (95 % CI)a, p value
Africa 67546
P50–P74 15747 6 · 3 1 · 00 – 4 · 3 1 · 00 –
P75–P89 10150 6 · 6 1 · 17 (1 · 05, 1 · 31) 0 · 0056 4 · 3 0 · 98 (0 · 86, 1 · 11) 0 · 7055
P90–P94 5247 5 · 7 1 · 07 (0 · 93, 1 · 24) 0 · 3383 5 · 0 1 · 07 (0 · 92, 1 · 25) 0 · 3900
P95–P96 1820 6 · 6 1 · 31 (1 · 05, 1 · 62) 0 · 0144 5 · 4 1 · 15 (0 · 91, 1 · 45) 0 · 2301
≥ P97 6851 7 · 2 1 · 54 (1 · 36, 1 · 75) <0 · 0001 5 · 8 1 · 10 (0 · 96, 1 · 26) 0 · 1794
Asia 91595
P50–P74 18066 5 · 0 1 · 00 – 1 · 8 1 · 00 –
P75–P89 14694 5 · 1 1 · 03 (0 · 92, 1 · 15) 0 · 5834 2 · 0 1 · 02 (0 · 86, 1 · 19) 0 · 8529
P90–P94 5955 4 · 8 1 · 04 (0 · 89, 1 · 21) 0 · 6389 1 · 7 0 · 88 (0 · 70, 1 · 11) 0 · 2784
P95–P96 3030 5 · 1 1 · 20 (0 · 98, 1 · 46) 0 · 0742 2 · 4 1 · 08 (0 · 83, 1 · 41) 0 · 5513
≥ P97 9574 6 · 4 1 · 41 (1 · 25, 1 · 59) <0 · 0001 2 · 5 1 · 12 (0 · 94, 1 · 34) 0 · 1909
Latin America 87518
P50–P74 20003 2 · 4 1 · 00 – 2 · 0 1 · 00 –
P75–P89 12912 2 · 7 1 · 13 (0 · 98, 1 · 30) 0 · 1014 2 · 2 1 · 10 (0 · 94, 1 · 29) 0 · 2236
P90–P94 5227 2 · 6 1 · 06 (0 · 87, 1 · 29) 0 · 5709 1 · 8 0 · 89 (0 · 71, 1 · 12) 0 · 3257
P95–P96 2242 2 · 9 1 · 21 (0 · 92, 1 · 58) 0 · 1744 2 · 1 0 · 98 (0 · 72, 1 · 34) 0 · 9162
≥ P97 6284 3 · 0 1 · 23 (1 · 03, 1 · 47) 0 · 0215 2 · 8 1 · 31 (1 · 09, 1 · 58) 0 · 0042
aAll estimates based on two-level logistic regression models. Facilities represent units at level two and individuals within facilities are observations at level one. We
adjusted for country, maternal age, marital status, education (total years of school attendance), obesity, diabetes, parity, infant sex, and gestational age
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macrosomia. Thus, a definition based on birthweight would
be more practical, especially in settings where accurate esti-
mation of gestational age may be difficult.
We observed that risks of elective and intrapartum
caesarean section increased significantly for infants with
a birthweight greater than 4000 g in the selected facil-
ities of all three regions. However, the risks of or vac-
uum extraction did not increase prominently, which
suggested that obstetricians may have a tendency for op-
erative delivery when faced with a suspiciously large
fetus and slow labor progress. Therefore, an estimated
birthweight of 4000 g may be a useful indicator for
difficult labour. We also found that risks of MMMI
and PMMI did not change substantially after excluding
elective caesarean deliveries, suggesting that suspected
macrosomic cases may not benefits from elective caesar-
ean section in a meaningful way. This was also demon-
strated in other studies [22, 23].
We also observed that risks of MMMI increased prior
to that of PMMI in three regions. This was consistent
with the three-level definition of macrosomia proposed
by Boulet et al. [3]: Grade 1 (>4000 g) to identify in-
creased risks of labour and newborn complications;
Grade 2 (>4500 g) to predict neonatal morbidity; and
Grade 3 (>5000 g) to predict infant mortality. The major
causes of maternal mortality and morbidity for mothers
of macrosomic babies included uterine atony, prolonged
labour, haemorrhage, vesico-vaginal/recto-vaginal fistula
and severe perineal laceration [21]. These complications
contributed to MMMI in our study. The most frequently
severe adverse outcome was admission to an intensive-
care unit (5.0 %), followed by blood transfusion (2.0 %)
and third or fourth degree perineal laceration (1.5 %) for
suspected macrosomia infants.
Macrosomia represents a significant obstetric challenge.
The definition of macrosomia has important clinical, med-
icolegal and cost implications. Therefore, it should be
evidence-based, particularly in resources limited countries
where skilled birth attendants and caesarean delivery may
not be readily available, and hospital transfer and special
care are costly. To the best of our knowledge, this is the
first study to search for an evidence-based definition of
macrosomia in LMICs.
However, our study has several limitations. First, the
significance of the definition of macrosomia using birth-
weight cut-off point in obstetric management is limited
by the inaccuracy in birthweight estimation. Either ultra-
sound or clinical prediction of birthweight is not accur-
ate enough to serve as the basis for obstetric decision
making. But obstetricians are prone to operative delivery
when faced with a suspected large fetus, which may lead
to unnecessary cesarean [24].
Second, despite the standardization of data collec-
tion, participating facilities may have different labour
management protocols. Inter-institutional variability is
inevitable due to the nature of a multinational study. For
example, screening for diabetes in pregnancy is not avail-
able in all facilities, particularly in Africa [2], and therefore
underestimation of gestational diabetes is likely. However,
our sensitivity analysis, which excluded the variable “dia-
betes” from the regression models, showed a similar result
to that of the fully adjusted models.
Third, information on maternal height and weight was
problematic in two aspects. More than 10 % of data for
height and/or weight were missing for some countries.
In addition, maternal weight was defined differently
across regions: in Africa and Latin America it was re-
ferred to as the first recorded weight at the first ante-
natal care visit while in Asia it was defined as the last
recorded weight before delivery. In theory, the last re-
corded maternal weight would better control for the po-
tential confounding effects of gestational weight gain in
Asia [25]. However, the results of the sensitivity analysis,
which excluded those countries or the variable “obesity”
from the regression model indicated that the limitation
did not affect the conclusion.
Finally, the sample used in the survey was selected
from facilities with more than 1000 deliveries per year
and where caesarean sections were available [11]. Selec-
tion bias is possible, especially in certain LMICs where
an institutional delivery rate is low. Therefore, the
generalizability of our findings may be limited.
Conclusions
A population-specific definition of macrosomia using
birthweight cut-off points (4500 g in Africa and Latin
America, 4000 g in Asia) for term infants at 37–42 ges-
tational weeks is more closely associated with maternal
and perinatal mortality and morbidity. This definition is
also easier to apply than that based on birthweight per-
centile for a given gestational age. The use of an
evidence-based definition of macrosomia may improve
obstetric and perinatal care, especially in resource-
limited settings in LMICs.
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